Previous close | 2.0300 |
Open | N/A |
Bid | 0.0000 |
Ask | 2.3500 |
Strike | 100.00 |
Expiry date | 2024-11-15 |
Day's range | 2.0300 - 2.0300 |
Contract range | N/A |
Volume | |
Open interest | 6 |
Fady Malik, Executive Vice President of Research & Development at Cytokinetics Inc (NASDAQ:CYTK), sold 7,788 shares of the company on June 11, 2024.
On June 10, 2024, Muna Bhanji, a Director at Cytokinetics Inc (NASDAQ:CYTK), sold 2,000 shares of the company at a price of $52.07 per share.
On June 3, 2024, B Parshall, Director at Cytokinetics Inc (NASDAQ:CYTK), executed a sale of 5,000 shares of the company.